Similarly, higher expression of SPARCL1 was correlated with better cell differentiation and less distant metastasis in colorectal cancers than those with lower expression of SPARCL1, and SPARCL1 was positively correlated with the prognosis of colorectal cancers (P < 0.01) [31]. This evidence concerns the gene SPARCL1 and colorectal cancer.